The Current Ratio as of December 2025 (TTM) for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is 1.83

According to Genomma Lab Internacional, S.A.B. de C.V.’s latest financial reports and current stock price. The company's current Current Ratio is 1.83. This represents a change of 3.10% compared to the average of 1.77 of the last 4 quarters.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Historical Current Ratio (quarterly & annually)

How has GNMLF Current Ratio performed in the past?

The mean historical Current Ratio of Genomma Lab Internacional, S.A.B. de C.V. over the last ten years is 1.78. The current 1.83 Current Ratio has changed 10.19% with respect to the historical average. Over the past ten years (40 quarters), GNMLF's Current Ratio was at its highest in in the September 2015 quarter at 3.65. The Current Ratio was at its lowest in in the September 2017 quarter at 1.20.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Genomma Lab Internacional, S.A.B. de C.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Average Current Ratio

How has GNMLF Current Ratio performed in the past?

The current Current Ratio of Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Current Ratio vs. Peers

How is GNMLF’s Current Ratio compared to its peers?

Genomma Lab Internacional, S.A.B. de C.V.’s Current Ratio is less than SSY Group Limited (3.12), less than Safilo Group S.p.A. (1.86), greater than Netcare Limited (1.15), less than Towa Pharmaceutical Co., Ltd. (2.82), less than BioGaia AB (publ) (6.27), less than Kissei Pharmaceutical Co., Ltd. (5.86), less than Rhoen-Klinikum AG (2.28), greater than Extendicare Inc. (0.85), less than Tong Ren Tang Technologies Co. Ltd. (4.82), less than RHON-KLINIKUM AG Unsponsored ADR (2.28),

Build a custom stock screener for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genomma Lab Internacional, S.A.B. de C.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genomma Lab Internacional, S.A.B. de C.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.